Nucor earnings beat by $0.08, revenue fell short of estimates
Daniel L. Reuvers, a director at Tactile Systems Technology Inc (NASDAQ:TCMD), recently sold 10,938 shares of the company’s common stock, according to a filing with the Securities and Exchange Commission. The transaction, which took place on February 24, 2025, was part of a pre-established 10b5-1 trading plan. The shares were sold at a weighted average price of $14.5499, generating a total of approximately $159,146.
The sale was conducted to cover taxes associated with the settlement of stock units, as noted in the filing. After this transaction, Reuvers retains direct ownership of 242,942 shares in Tactile Systems Technology. The stock has experienced a significant 14% decline over the past week, though InvestingPro analysis indicates the company remains undervalued based on its Fair Value assessment.
Earlier, on February 20, 2025, Reuvers acquired 15,853 performance stock units (PSUs) at no cost. These units were earned based on the company’s performance in 2024, with the PSUs vesting on the same day. Following these transactions, Reuvers’ total shareholding in the company remains substantial.
In other recent news, Tactile Systems Technology reported better-than-expected earnings for the fourth quarter of 2024. The company achieved earnings per share of $0.40, surpassing the forecast of $0.31, and generated revenues of $85.6 million, slightly above the anticipated $85.41 million. Despite these positive results, analysts at B. Riley downgraded Tactile Systems from Buy to Neutral, adjusting the price target to $18. This downgrade was influenced by concerns over slowing earnings growth and ongoing legal challenges, including qui tam lawsuits. The company’s fiscal year 2025 guidance projects revenues between $316 million and $322 million, aligning with analysts’ expectations, but the adjusted EBITDA forecast falls short of the consensus. Additionally, Tactile Systems is focusing on expanding its lymphedema and airway clearance product lines. The company highlighted new product launches and innovations during its earnings call, although it continues to face external challenges.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.